 |
 |
PharmaVOICE - April 2010 Software as a Service: Gaining Traction By Robin Robinson Many research firms have predicted that the worldwide economic recession is responsible for the global increase in the software-as-a-service (SaaS) market revenue. According to a recent Gartner report, SaaS is forecast to have a 17.7% compound annual growth rate through 2013 for the aggregate enterprise application markets, representing a compound annual growth rate of almost five times the total application market of 3.6%. While cost is always a factor in decision-making, the increasing uptake of SaaS in the pharmaceutical industry is all about flexibility, our experts say. Currently, sales and marketing is the most common vertical to employ SaaS, but as more applications mature, the industry will expand its use of SaaS to more areas, such as human resources, call centers, supply chain, compliance, and clinical applications. According to Forrester Research, overall SaaS is experiencing growth in up to 13 areas, including archiving and e-discovery, business intelligence, collaboration, CRM, digital asset... Sidebar: SaaS Knockoffs: Seven Ways to Spot a Fake SaaS is Not a One-Size-Fits-All Solution THOUGHT LEADERS Ken Arbadji. VP, StayinFront, a global provider of CRM and decision-support solutions. For more information, visit stayinfront.com. Leila Daiuto. Sales Director, Axentis, a part of ARC Logics, a Wolters Kluwer business, which provides governance, risk, and compliance management software. For more information, visit axentis.com. Jamie Duke. Chief Operating Officer, SciQuest Inc., which provides global procurement automation and supplier enablement solutions. For more information, visit sciquest.com. Dominic John. Director of Software Marketing, Symyx Technologies Inc., a provider of software solutions for the electronic laboratory environment that transform scientific R&D. For more information, visit symyx.com. DeWayne Manning, R.Ph. President, DiseaseTrak, a specialty healthcare services company that creates and manages patient management solutions. For more information, visit diseasetrak.com. Ken Parmelee. Director of Application Development, Antenna Software, which enables organizations to design, build, deploy, and manage secure mobile applications. For more information, visit antennasoftware.com. Jo Ann Saitta. Senior VP, PDI Inc., which provides commercialization services for established and emerging biopharmaceutical companies. For more information, visit pdi-inc.com. Nagaraja Srivatsan. VP and Head of Life Sciences, North America, Cognizant, which offers IT, consulting, analytics, and business process outsourcing services to global pharma, biotech, and medical-device companies. For more information, visit cognizant.com. Matt Wallach. Executive VP and General Manager, Veeva Systems, which develops SaaS applications for the global life-sciences industry. For more information, visit veevasystems.com. Steve Webb. Chairman, Interactive Medica, which supplies SaaS applications to the life-sciences industry. For more information, visit interactivemedica.com. Mike Wexler. Founding Principal, Biltmore Technologies Inc., which offers SaaS business intelligence solutions and technology consulting to sales and marketing divisions of pharmaceutical and biotech companies. For more information, visit biltmoretech.com or e-mail mwexler@biltmoretech.com.
|
